During the past decade, Urologische Klinik Dr. Castringius - München-Planegg conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urologische Klinik Dr. Castringius - München-Planegg" #1 sponsor was "Immatics Biotechnologies GmbH" with 2 trials, followed by "Photocure" with 2 trials sponsored, "BioNTech SE" with 1 trials sponsored, "Cubist Pharmaceuticals LLC" with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Urologische Klinik Dr. Castringius - München-Planegg" are "Bladder Cancer" (2 trials), "Prostate Cancer" (2 trials), "Complicated Urinary Tract Infection" (1 trials), "Metastatic Renal Cell Carcinoma" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Urologische Klinik Dr. Castringius - München-Planegg" in a lesser frequency.

Most popular intervention types in "Urologische Klinik Dr. Castringius - München-Planegg" are "Drug" (6 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "BNT112" (1 trials), "Bicalutamide" (1 trials), "CXA-101" (1 trials), "Ceftazidime" (1 trials) and "Cemiplimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urologische Klinik Dr. Castringius - München-Planegg" are 5 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Urologische Klinik Dr. Castringius - München-Planegg". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Urologische Klinik Dr. Castringius - München-Planegg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Urologische Klinik Dr. Castringius - München-Planegg, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".